LONDON (Thomson Financial) - ReNeuron Group PLC said its scientists have generated human pancreatic cell lines for treatment of diabetes. It added these cell lines form clusters which were shown to secrete insulin in response to glucose concentrations, thus demonstrating potential as a therapy candidate for insulin-dependent patients.
